Cox and mesothelioma: an overview. [Histol Histopathol. 2005]

SearchDatabase nameforSearch term

Advanced Search (beta)

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 1

Click to change filter selection through MyNCBI.

1: Histol Histopathol. 2005 Oct;20(4):1267-74. Links

Cox and mesothelioma: an overview.

Cardillo I, Spugnini EP, Verdina A, Galati R, Citro G, Baldi A.

SAFU Department, Center for Experimental Research, Regina Elena Cancer Institute, Rome, Italy.

Cyclooxygenases catalyze the rate limiting step in the production of prostanoids. Accumulating data demonstrate that overexpression of these enzymes, and in particular of cyclooxygenases-2, promotes multiple events involved in tumorigenesis; in addition, numerous studies show that inhibition of cyclooxygenases-2 can delay or prevent certain forms of cancer. Malignant mesothelioma is a lethal pleural, peritoneal and pericardial neoplasia that actually lacks valid therapies and in which cyclooxygenases-2 is recognized as an important adverse prognostic factor. Hence, there is an increasing interest in the development of new treatments based on cyclooxygenases-2 inhibitors, to prolong survival and even potentially cure this neoplasia.

PMID: 16136507 [PubMed - indexed for MEDLINE]

Cyclooxygenases in hepatocellular carcinoma. [World J Gastroenterol. 2006]
Chemical and structural diversity in cyclooxygenase protein active sites. [Chem Biodivers. 2005]
Synthesis of 2-methyl-3-indolylacetic derivatives as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 without gastric damage. [J Med Chem. 2006]
Structural and functional differences between cyclooxygenases: fatty acid oxygenases with a critical role in cell signaling. [Biochem Biophys Res Commun. 2005]
The role of the cylooxygenase pathway in nociception and pain. [Semin Cell Dev Biol. 2006]
» See all Related Articles...

Display Show

Cox and mesothelioma: an overview.

Related Articles